You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 70000-0083


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70000-0083

Drug Name NDC Price/Unit ($) Unit Date
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11364 EACH 2025-01-22
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11597 EACH 2024-12-18
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11453 EACH 2024-11-20
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11741 EACH 2024-10-23
HEAD CONGESTION-MUCUS CAPLET 70000-0083-01 0.11283 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 70000-0083

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 70000-0083

Understanding the NDC Directory

To analyze the market and project prices for a specific drug, such as the one identified by the National Drug Code (NDC) 70000-0083, it is crucial to understand the sources of data and the context in which these drugs operate.

The FDA's National Drug Code Directory is a comprehensive resource that contains information on finished drug products, unfinished drugs, and compounded drug products. This directory includes data on active and certified finished and unfinished drugs submitted by labelers, which can be manufacturers, repackagers, or relabelers[1][4].

Identifying the Drug

To start the analysis, one must identify the drug associated with the NDC 70000-0083. The NDC Directory can be searched using the proprietary name, application number, labeler name, active ingredient, or the NDC number itself. However, without direct access to the current database or specific details from the directory, we must rely on general principles of drug market analysis.

Market Trends in Prescription Drugs

The prescription drug market is characterized by several key trends:

  • Price Increases: Many prescription drugs have seen significant price increases over the years. For example, between 2018 and 2023, nine out of ten drugs selected for Medicare Part D negotiations experienced list price increases ranging from 20% to 55%[2].
  • Global Price Disparities: The United States has notably higher prescription drug prices compared to other countries. In 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[3].
  • Segmented Market Growth: The market for prescription drugs is segmented, with different growth trends for small molecule drugs and biologic products. In the U.S., sales revenues for biologic products grew significantly, by 61%, between 2017 and 2022[3].

Price Projections

Historical Price Data

For accurate price projections, historical price data is essential. Websites like DrugPatentWatch provide wholesale price data for specific NDCs. Although the exact prices for NDC 70000-0083 are not provided here, similar drugs can be used as benchmarks. For instance, the wholesale prices for another drug (NDC 70000-0043) have been relatively stable over recent months, fluctuating slightly around $0.51 per gram[5].

Regulatory and Negotiation Impacts

Regulatory changes and negotiation programs can significantly impact drug prices. The Medicare Drug Price Negotiation Program, for example, has resulted in substantial discounts for selected drugs, ranging from 38% to 79% compared to list prices[2].

Market Forces

Market forces such as demand, competition, and supply chain dynamics also influence drug prices. An increase in demand or a shortage in supply can drive prices up, while increased competition from generics or biosimilars can lead to price reductions.

Projecting Prices for NDC 70000-0083

Given the lack of specific historical data for NDC 70000-0083, here are some general projections based on market trends:

  • Short-Term Stability: If the drug is well-established and has a stable market presence, prices might remain relatively stable in the short term, similar to the pattern observed for other drugs.
  • Long-Term Adjustments: Over the long term, prices could be influenced by regulatory changes, such as those from the Medicare Drug Price Negotiation Program, or by shifts in market demand and competition.
  • Global Comparisons: If the drug is priced significantly higher in the U.S. compared to other countries, there might be pressure to reduce prices to align more closely with international standards.

Key Factors Influencing Price Projections

Regulatory Environment

Changes in regulatory policies, such as the Medicare Drug Price Negotiation Program, can lead to significant price reductions for certain drugs[2].

Market Competition

The introduction of generic or biosimilar versions of the drug can lead to price competition, potentially reducing the price of the branded drug.

Demand and Supply

Changes in demand due to epidemiological trends or supply chain disruptions can impact prices. For example, an increase in the prevalence of a condition treated by the drug could drive up demand and, consequently, prices.

International Pricing

The disparity in drug prices between the U.S. and other countries may lead to calls for price adjustments to make the drug more affordable in the U.S. market[3].

Conclusion

Projecting prices for a specific drug like NDC 70000-0083 requires a detailed analysis of historical price data, market trends, regulatory changes, and global pricing disparities. Here are some key takeaways:

  • Historical Data: Essential for understanding price stability and trends.
  • Regulatory Impact: Programs like the Medicare Drug Price Negotiation Program can significantly reduce prices.
  • Market Forces: Demand, competition, and supply chain dynamics play crucial roles.
  • Global Pricing: U.S. prices are often higher than those in other countries, which could influence future price adjustments.

Key Takeaways

  • Use Historical Data: Analyze past price trends to predict future stability or changes.
  • Monitor Regulatory Changes: Keep track of programs like the Medicare Drug Price Negotiation Program.
  • Assess Market Competition: Watch for the introduction of generics or biosimilars.
  • Consider Global Pricing: Be aware of international price disparities and potential adjustments.
  • Evaluate Demand and Supply: Changes in demand or supply can significantly impact prices.

FAQs

Q: What is the National Drug Code (NDC) Directory? A: The NDC Directory is a database maintained by the FDA that contains information on finished drug products, unfinished drugs, and compounded drug products in the U.S.[1].

Q: How do regulatory changes impact drug prices? A: Regulatory changes, such as the Medicare Drug Price Negotiation Program, can lead to significant discounts on drug prices, ranging from 38% to 79% compared to list prices[2].

Q: Why are drug prices in the U.S. higher than in other countries? A: Drug prices in the U.S. are often higher due to a combination of factors including higher prices for the same drugs and a drug mix that skews towards more expensive compounds[3].

Q: What role does market competition play in drug pricing? A: Market competition, especially from generics or biosimilars, can drive down the prices of branded drugs by increasing competition and reducing demand for the more expensive options.

Q: How can global pricing trends influence U.S. drug prices? A: Global pricing trends can influence U.S. drug prices by highlighting disparities and potentially leading to calls for price adjustments to make drugs more affordable in the U.S. market[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Medicare Drug Price Negotiation Program - ASPE, HHS.gov
  3. International Market Size and Prices - ASPE, HHS.gov
  4. NDC Directory (March 2015) - FDA
  5. Latest drug prices and trends for NDC 70000-0043 - DrugPatentWatch

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.